Loading stock data...

Neuland Laboratories Limited

NSE: NEULANDLAB BSE: NEULANDLAB

NSE
13,910.00 70.00 (0.51%)

Prev Close

13840

Open Price

13890

Volume

72,265

Today Low / High

13725 / 14315

52 WK Low / High

8651.05 / 18100

Range

13,215 - 14,606

BSE
13,904.45 55.35 (0.40%)

Prev Close

13849.1

Open Price

13456.2

Volume

5,086

Today Low / High

13456.2 / 14300

52 WK Low / High

8669.4 / 18089.55

Range

13,209 - 14,600

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 13910 (target range: 13,215 - 14,606), reflecting a change of 70 (0.50578%). On the BSE, it is listed at 13904.45 (target range: 13,209 - 14,600), showing a change of 55.35 (0.39966%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

30 Jul 13,890.00 0.17%
29 Jul 13,945.00 -0.75%
28 Jul 13,700.00 1.28%
25 Jul 13,811.00 -0.37%
24 Jul 13,726.00 0.55%
23 Jul 13,992.00 -1.97%
22 Jul 14,143.00 -1.07%
21 Jul 14,265.00 -0.86%
18 Jul 14,503.00 -1.65%
17 Jul 14,400.00 0.72%
16 Jul 15,010.00 -4.19%
15 Jul 14,751.00 3.54%
14 Jul 12,303.00 18.25%
11 Jul 11,880.00 3.54%
10 Jul 12,074.00 -1.61%
09 Jul 11,706.00 2.24%
08 Jul 11,786.00 -0.68%
07 Jul 11,999.00 -1.78%
04 Jul 11,755.00 2.08%
03 Jul 12,007.00 -2.82%
02 Jul 11,871.00 0.94%

Neuland Laboratories Limited Graph

Neuland Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Neuland Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 13,910.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 13,904.45 14,043.49 12,639.15 - 15,447.84
14,182.54 11,346.03 - 17,019.05
14,321.58 10,025.11 - 18,618.06
Bearish Scenario 13,904.45 13,765.41 12,388.86 - 15,141.95
13,626.36 10,901.09 - 16,351.63
13,487.32 9,441.12 - 17,533.51

Overview of Neuland Laboratories Limited

ISIN

INE794A01010

Industry

Drug Manufacturers - Specialty & Generic

Vol.Avg

92,837

Market Cap

178,463,909,000

Last Dividend

12

Official Website

Visit Website

IPO Date

2008-10-13

DCF Diff

-821.78

DCF

14,732

Financial Ratios Every Investor Needs

Stock Dividend of NEULANDLAB

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-07-18 July 18, 25 12 12 2025-07-18 2025-08-08
2024-07-12 July 12, 24 14 14 2024-07-12 2024-08-30
2023-07-11 July 11, 23 10 10 2023-07-11 2023-08-26
2022-07-14 July 14, 22 5 5 2022-07-15 2022-09-01
2021-06-29 June 29, 21 3 3 2021-06-30 2021-08-03

Stock Rating Details for NEULANDLAB

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 3 Neutral
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 1,476.84 Cr 750.51 Cr 726.33 Cr 0.4918 0.00 Cr 0.00 Cr 257.71 Cr 260.11 Cr 202.74 420.17 Cr 0.1761
2024-03-31 1,558.58 Cr 733.80 Cr 824.78 Cr 0.5292 43.50 Cr 30.92 Cr 531.81 Cr 300.08 Cr 233.89 474.82 Cr 0.1925
2023-03-31 1,160.90 Cr 613.79 Cr 547.11 Cr 0.4713 27.76 Cr 29.89 Cr 234.34 Cr 163.52 Cr 127.45 279.18 Cr 0.1409
2022-03-31 923.33 Cr 553.50 Cr 369.83 Cr 0.4005 0.36 Cr 15.69 Cr 96.09 Cr 63.82 Cr 49.74 140.40 Cr 0.0691
2021-03-31 918.18 Cr 554.72 Cr 363.46 Cr 0.3958 21.07 Cr 13.49 Cr 109.63 Cr 80.63 Cr 62.85 162.91 Cr 0.0878

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 131.93 Cr 2,179.88 Cr 655.08 Cr 1,524.8063 Cr 157.14 Cr 25.21 Cr 385.76 Cr 718.27 Cr 0.00 Cr 0.00 Cr 1.53 Cr 465.6859 Cr
2024-03-31 87.58 Cr 1,832.56 Cr 549.86 Cr 1,282.7048 Cr 95.39 Cr 7.81 Cr 350.42 Cr 568.61 Cr 81.17 Cr 0.00 Cr 13.76 Cr 427.6832 Cr
2023-03-31 45.42 Cr 1,579.76 Cr 585.67 Cr 994.0965 Cr 128.45 Cr 83.03 Cr 279.23 Cr 498.00 Cr 136.56 Cr 0.00 Cr 0.00 Cr 438.9570 Cr
2022-03-31 5.09 Cr 1,383.49 Cr 542.99 Cr 840.5008 Cr 240.53 Cr 235.44 Cr 265.21 Cr 486.58 Cr 0.00 Cr 0.00 Cr 0.50 Cr 363.1566 Cr
2021-03-31 2.44 Cr 1,324.79 Cr 538.33 Cr 786.4577 Cr 182.29 Cr 179.86 Cr 247.61 Cr 431.23 Cr 63.61 Cr 0.03 Cr -7.68 Cr 368.5109 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 317.3828 Cr -298.1559 Cr 24.9610 Cr 110.9188 Cr 44.3550 Cr 131.9304 Cr -206.4640 Cr 346.3290 Cr 55.3429 Cr -17.9618 Cr -35.3350 Cr
2024-03-31 261.1767 Cr -149.6868 Cr -69.2818 Cr 117.5069 Cr 42.1595 Cr 87.5754 Cr -143.6698 Cr 300.0789 Cr -39.4402 Cr -12.8299 Cr -71.1885 Cr
2023-03-31 237.2119 Cr -61.4985 Cr -135.7956 Cr 171.0834 Cr 40.3245 Cr 45.4159 Cr -66.1285 Cr 215.2129 Cr -113.5815 Cr -6.4149 Cr -14.0233 Cr
2022-03-31 60.3888 Cr -95.5163 Cr 37.7215 Cr -37.2972 Cr 2.6558 Cr 5.0914 Cr -97.6860 Cr 82.1625 Cr 20.3341 Cr -3.8490 Cr -17.6024 Cr
2021-03-31 189.3617 Cr -84.4237 Cr -113.6604 Cr 83.9647 Cr -8.7679 Cr 2.4356 Cr -105.3970 Cr 105.3335 Cr -89.6629 Cr -2.5660 Cr -28.0603 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 328.36 Cr 171.99 Cr 156.37 Cr 0.4762 34.18 Cr 27.81 Cr 21.67 58.54 Cr 0.0847
2024-12-31 398.03 Cr 205.72 Cr 192.31 Cr 0.4831 70.30 Cr 101.59 Cr 79.18 146.28 Cr 0.2552
2024-09-30 310.84 Cr 159.76 Cr 151.09 Cr 0.4861 46.15 Cr 32.84 Cr 25.60 66.56 Cr 0.1057
2024-06-30 439.60 Cr 302.46 Cr 137.15 Cr 0.3120 107.08 Cr 97.87 Cr 76.28 148.79 Cr 0.2226
2024-03-31 385.01 Cr 180.02 Cr 204.99 Cr 0.5324 90.45 Cr 67.56 Cr 52.66 109.35 Cr 0.1755

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 131.93 Cr 107.68 Cr 368.72 Cr 315.72 Cr 385.76 Cr 1,139.50 Cr 718.27 Cr 2,179.88 Cr 655.08 Cr
2024-12-31 0.00 Cr 0.00 Cr 190.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,395.21 Cr
2024-09-30 72.47 Cr 125.03 Cr 197.51 Cr 305.93 Cr 386.46 Cr 966.48 Cr 669.99 Cr 1,943.80 Cr 548.59 Cr
2024-06-30 -87.58 Cr 175.15 Cr 87.58 Cr 0.00 Cr 0.00 Cr 87.58 Cr 0.00 Cr 0.00 Cr -1,282.70 Cr
2024-03-31 87.58 Cr 15.01 Cr 102.59 Cr 375.99 Cr 350.42 Cr 921.08 Cr 568.61 Cr 1,832.56 Cr 549.86 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 27.81 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 101.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 32.84 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 97.87 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 67.56 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2014-08-13 August 13, 14 523:500
2012-03-21 March 21, 12 289:250

Similar Stocks: Drug Manufacturers - Specialty & Generic

Company Name Symbol Price Market Cap Volume
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,733.80 ₹4,159,871,664,000.00 ₹2,318,664.00
Divi's Laboratories Limited DIVISLAB ₹6,650.00 ₹1,765,368,850,000.00 ₹226,973.00
Torrent Pharmaceuticals Limited TORNTPHARM ₹3,730.60 ₹1,262,602,917,000.00 ₹439,520.00
Dr. Reddy's Laboratories Limited DRREDDY ₹1,292.10 ₹1,075,456,274,108.00 ₹1,386,961.00
Mankind Pharma Limited MANKIND ₹2,575.50 ₹1,062,982,921,380.00 ₹763,328.00
Zydus Lifesciences Limited ZYDUSLIFE ₹995.15 ₹1,001,349,784,500.00 ₹775,382.00
Lupin Limited LUPIN ₹1,984.60 ₹906,460,096,200.00 ₹754,124.00
Aurobindo Pharma Limited AUROPHARMA ₹1,158.00 ₹672,568,716,000.00 ₹672,249.00
Alkem Laboratories Limited ALKEM ₹5,099.60 ₹609,733,674,000.00 ₹69,765.00
Glenmark Pharmaceuticals Limited GLENMARK ₹2,153.60 ₹607,748,073,600.00 ₹786,090.00
Laurus Labs Limited LAURUSLABS ₹881.45 ₹475,603,095,050.00 ₹5,551,173.00
Suven Pharmaceuticals Limited SUVENPHAR ₹1,078.00 ₹412,407,234,624.00 ₹1,177,218.00
Ipca Laboratories Limited IPCALAB ₹1,529.50 ₹388,040,268,000.00 ₹501,348.00
Cohance Lifesciences Limited COHANCE ₹997.40 ₹381,572,333,779.00 ₹30,739.00
Ajanta Pharma Limited AJANTPHARM ₹2,800.50 ₹349,816,056,000.00 ₹68,739.00
Piramal Enterprises Limited PEL ₹1,287.60 ₹291,870,592,800.00 ₹4,377,271.00
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM ₹1,782.60 ₹278,652,466,800.00 ₹198,162.00
Wockhardt Limited WOCKPHARMA ₹1,684.80 ₹273,744,619,200.00 ₹253,355.00
Eris Lifesciences Limited ERIS ₹1,816.60 ₹247,415,470,200.00 ₹258,998.00
AstraZeneca Pharma India Limited ASTRAZEN ₹9,340.00 ₹233,500,000,000.00 ₹39,783.00
Alembic Pharmaceuticals Limited APLLTD ₹1,007.60 ₹198,056,878,800.00 ₹43,245.00
Jubilant Pharmova Limited JUBLPHARMA ₹1,236.30 ₹196,919,100,300.00 ₹1,978,762.00
Neuland Laboratories Limited NEULANDLAB ₹13,910.00 ₹178,463,909,000.00 ₹72,265.00
NATCO Pharma Limited NATCOPHARM ₹973.15 ₹174,300,896,500.00 ₹709,365.00
Caplin Point Laboratories Limited CAPLIPOINT ₹2,145.80 ₹163,105,905,860.00 ₹121,630.00
Glenmark Life Sciences Limited GLS ₹1,086.00 ₹133,070,838,000.00 ₹130,938.00
Granules India Limited GRANULES ₹492.15 ₹119,417,244,600.00 ₹954,418.00
Procter & Gamble Health Limited PGHL ₹5,947.00 ₹98,716,631,800.00 ₹41,877.00
Shilpa Medicare Limited SHILPAMED ₹919.15 ₹89,884,505,735.00 ₹41,687.00
Strides Pharma Science Limited STAR ₹945.35 ₹87,126,008,445.00 ₹401,712.00
Aarti Pharmalabs Limited AARTIPHARM ₹946.50 ₹85,785,667,830.00 ₹174,284.00
FDC Limited FDC ₹484.45 ₹78,873,304,500.00 ₹30,593.00
Suven Life Sciences Limited SUVEN ₹269.30 ₹58,727,328,200.00 ₹85,394.00
Innova Captab Limited INNOVACAP ₹917.50 ₹52,503,873,275.00 ₹36,415.00
Sun Pharma Advanced Research Company Limited SPARC ₹151.93 ₹49,304,627,460.00 ₹195,988.00
Aarti Drugs Limited AARTIDRUGS ₹522.25 ₹47,665,757,500.00 ₹446,949.00
Sequent Scientific Limited SEQUENT ₹175.86 ₹44,023,913,100.00 ₹235,318.00
Unichem Laboratories Limited UNICHEMLAB ₹619.85 ₹43,641,035,130.00 ₹39,695.00
Hikal Limited HIKAL ₹329.80 ₹40,664,669,800.00 ₹316,649.00
Gufic Biosciences Limited GUFICBIO ₹404.55 ₹40,567,464,900.00 ₹352,761.00
RPG Life Sciences Limited RPGLIFE ₹2,405.80 ₹39,789,526,200.00 ₹52,499.00
Orchid Pharma Limited ORCHPHARMA ₹705.15 ₹35,764,573,365.00 ₹37,012.00
Morepen Laboratories Limited MOREPENLAB ₹59.69 ₹32,707,374,260.00 ₹1,444,289.00
Solara Active Pharma Sciences Limited SOLARA ₹651.90 ₹31,390,940,700.00 ₹124,331.00
Indoco Remedies Limited INDOCO ₹324.50 ₹29,934,443,550.00 ₹64,322.00
IOL Chemicals and Pharmaceuticals Limited IOLCP ₹100.29 ₹29,437,822,830.00 ₹15,953,556.00
Alembic Limited ALEMBICLTD ₹114.24 ₹29,334,775,566.00 ₹212,418.00

Key Executives

Company Secretary & Compliance Officer
Ms. Sarada Bhamidipati

Gender: female

Year Born:

Chief Financial Officer
Mr. Abhijit Majumdar

Gender: male

Year Born:

Executive Chairman & Chief Promoter and Member of Scientific Advisory Board
Dr. Davuluri Rama Mohan Rao

Gender: Not Specified

Year Born: 1944

Chief Scientific Officer & Member of Scientific Advisory Board
Dr. Sharadsrikar Venkatesan Kotturi

Gender: Not Specified

Year Born:

Chief Human Resources Officer
Mr. Hemchandra Peruvelli

Gender: male

Year Born: 1972

Vice Chairman & Chief Executive Officer
Mr. Davuluri Sucheth Rao

Gender: male

Year Born: 1975

President of Business Development & Contract Manufacturing
Mr. Shashank Mahashabde

Gender: male

Year Born:

Chief Procurement Officer
Mr. N. Sundar

Gender: male

Year Born: 1968

Vice Chairman & MD
Mr. Davuluri Saharsh Rao

Gender: male

Year Born: 1979

Senior Vice President of Global Head Sales & BD
Mr. Sudheer Yarabolu

Gender: male

Year Born:

FAQs about Neuland Laboratories Limited

Who is the CEO of the company?

The CEO is Davuluri Sucheth Rao.

What is the current market price of the stock?

The current price is ₹13,910.00.

What is the 52-week price range?

The range is ₹8651.05-18100.

What is the market capitalization of the company?

The market capitalization is ₹17,846.39 crores.

What is the dividend yield?

The dividend yield is 0.09%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 68.61.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Neuland Laboratories Limited (ISIN: INE794A01010) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹17,846.39 crores and an average daily volume of 92,837 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹12.